-
Mashup Score: 0
The conversation of VLR has sparked a discussion as to whether or not other COVID-19 treatment agents are associated with a surge in symptoms and if so, how those agents compare with the rebound effect of nirmatrelvir/ritonavir.
Source: www.pharmacytimes.comCategories: General Medicine News, General Journals & SocietTweet
-
Mashup Score: 1FDA Approves Crinecerfont for Adult, Pediatric Patients with Congenital Adrenal Hyperplasia - 10 hour(s) ago
The decision is based on positive results from the CAHtalyst trials, which both met their primary and secondary end points.
Source: www.pharmacytimes.comCategories: General Medicine News, General Journals & SocietTweet-
Read more here: https://t.co/us2h8Q4NGE
-
-
Mashup Score: 1Pathways to Improve Overall Survival in Myelofibrosis: Finding Alternate Trial End Points - 13 hour(s) ago
Measuring end points such as molecular response, cytokines, and histomorphometry may show a greater range of benefits.
Source: www.pharmacytimes.comCategories: General Medicine News, General Journals & SocietTweet-
Read more here: https://t.co/mC3NOiYYF7
-
-
Mashup Score: 1IVIG Identified as a Treatment Marker of High Medical Costs, Resource Utilization in Patients With Myasthenia Gravis - 16 hour(s) ago
Often used as a treatment for severe exacerbations of myasthenia gravis, intravenous immunoglobulin can lead to high financial toxicity and resource utilization.
Source: www.pharmacytimes.comCategories: General Medicine News, General Journals & SocietTweet-
Read more here: https://t.co/PIvMUfTQSc
-
-
Mashup Score: 2Empowering Pharmacists: Navigating Pediatric OTC Medications and Building Trust With Parents - 1 day(s) ago
Key opinion leaders provide pharmacists with essential guidance on the appropriate dosing and administration of over-the-counter medications for common pediatric conditions, while equipping them with strategies to effectively counsel parents on symptom identification, condition management, and when to seek medical advice for children’s health issues.
Source: www.pharmacytimes.comCategories: General Medicine News, PayerTweet-
Listen in to Trisha Winroth, PharmD and Ashly McPhillips, PharmD as they dive into #pediatric OTC medication management. Learn about proper dosing, building parent rapport, and safe storage to improve #patientcare. Watch now: https://t.co/0tNdkK5Bm1 https://t.co/oHxnOnADZr
-
-
Mashup Score: 0SABCS 2024: Identifying High-Risk Women for Targeted Breast Cancer Prevention Through AI-Powered Mammography Analysis - 1 day(s) ago
AI-powered analysis of mammography images can identify women at high long-term risk of breast cancer, enabling targeted prevention strategies.
Source: www.pharmacytimes.comCategories: General Medicine News, PayerTweet-
#SABCS: Epidemiologist Mikael Eriksson, PhD, explains the use of artificial intelligence (#AI)-based analysis of mammography images to assess long-term breast #cancer risk & identify #women who could benefit from preventive interventions. Watch: https://t.co/pClabX1PdX
-
-
Mashup Score: 2
Advancements in prevention address cancer risk in high-risk patients and BRCA mutation carriers.
Source: www.pharmacytimes.comCategories: General Medicine News, General Journals & SocietTweet-
#SABCS: Advancements in prevention and treatment strategies in breast cancer, including MUC1 #vaccines, tamoxifen, and denosumab, can address cancer risk in high-risk patients and BRCA mutation carriers. #BreastCancer Read more: https://t.co/tClfBvPQfm
-
-
Mashup Score: 6Exploring the Role of Tumor Biology in Redefining Triple-Negative Breast Cancer Treatment - 2 day(s) ago
Emerging research in triple-negative breast cancer highlights the promise of molecular-based approaches to improve treatment outcomes.
Source: www.pharmacytimes.comCategories: General Medicine News, General Journals & SocietTweet-
#SABCS: New research in #tumor biology is redefining treatment for triple-negative breast cancer, offering hope for more effective therapies based on molecular approaches. #BreastCancer Read more: https://t.co/GicwCDW3TH
-
-
Mashup Score: 4FDA Approves Tapinarof Cream 1% for Treatment of Atopic Dermatitis in Adults, Children 2 Years and Older - 2 day(s) ago
The approval builds on previous indications for tapinarof, an aryl hydrocarbon receptor agonist, for the topical treatment of atopic dermatitis.
Source: www.pharmacytimes.comCategories: General Medicine News, General Journals & SocietTweet-
Breaking News: The #FDA has approved tapinarof (Vtama; Organon) cream, 1%, for an additional indication of the topical treatment of atopic #dermatitis (AD) in adults and pediatric patients 2 years and older. Coverage continues here: https://t.co/KIBOfxHZVM
-
-
Mashup Score: 0Dual-Targeted Therapy With Ruxolitinib and Duvelisib: Optimizing Treatment for T-Cell Lymphomas Through Pharmacist Collaboration - 2 day(s) ago
Alison Moskowitz, MD, discusses the clinical considerations, dosing strategies, and the critical role of pharmacists in managing toxicities and tailoring treatment plans for dual-targeted therapy with ruxolitinib and duvelisib.
Source: www.pharmacytimes.comCategories: General Medicine News, General Journals & SocietTweet-
#ASH2024: Alison Moskowitz, MD, discusses the essential role of pharmacists in determining proper dosing and tailoring treatment plans when combining ruxolitinib and duvelisib for the treatment of peripheral T-cell #lymphomas. Read more: https://t.co/45kqqMwZDK
-
Read more here: https://t.co/lLYbDsOxEV